FDA Grants Breakthrough Therapy Designation to Seres Therapeutics’ SER-155 for Reduction of Bloodstream Infections in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)

Published: 12/09/2024

Latest News

NEWS 03.05.2026

Government Hosts Youth Engagement Conference in Bengaluru – Observer Voice

NEWS 03.05.2026

Polycythemia Market Expected to Reach $6.53 Billion by 2030 – Comprehensive Report from The Business Research Company – Weekly Voice

NEWS 03.05.2026

Longevity And Anti-Senescence Therapy Market 2026: Unlock Breakthrough Therapies Extending Healthy Lifespan – Weekly Voice

NEWS 03.05.2026

Leading celebrity surgeon Dr Matee Rajput redefines modern ageing with expansion into elite wellness, longevity medicine and aesthetics – London Daily News